June 16, 2010 (San Antonio, Texas) — Gabapentin enacarbil (GEn) improves both objective and subjective sleep disturbance among patients with primary restless legs syndrome (RLS), according to a study ...
August 4, 2011 — A new study is the first long-term prospective trial of dopamine agonist therapy in restless legs syndrome (RLS). The study, funded by UCB BioSciences and Schwarz Pharma, ...
Restless Legs Syndrome (RLS), or Willis-Ekbom disease (WED) is one of the most common chronic sensorimotor neurological conditions encountered by clinicians. It occurs in 5% to 10% of the adult ...
DARIEN, IL - A new clinical practice guideline developed by the American Academy of Sleep Medicine provides updated recommendations for the treatment of restless legs syndrome. The guideline reflects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results